Skip to content

Impact of L-Carnitine supplementation for hemodialysis patients with heart failure.

Impact of L-Carnitine supplementation for hemodialysis patients with heart failure. - Impact of L-Carnitine supplementation for hemodialysis patients with heart failure.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000011498
Enrollment
30
Registered
2013-08-16
Start date
2013-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis patients, heart failure

Interventions

duration: 6 months. amount:L-Cartin FF injection 1000mg or 900 mg of L-carnitine. times: 3 times per week after HD sessions or orally intake.

Sponsors

Department of Blood purification, Kidney Center, Tokyo Women's Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1, More than dialysis history 3 year 2, sufficient understanding top after being given to sufficient explanation in the participation in this research, and a patient -- the patient by whom the document consent by the free will of the person himself/herself was got 3, The patient who had the view of the contractile dysfunction of the left ventricle, or heart failure with preserved ejection fraction in the cardiac echo check for the past less than 12 months

Exclusion criteria

Exclusion criteria: 1, A patient with the past of allergy to L-carnitine 2, A pregnant woman or the woman that may have become pregnant 3, The patient who took the supplement of carnitine less than 1 month before registration 4, The patient who judged that a principal investigator was unsuitable as a subject 5, A patient with a high possibility that spring suit medicine will be uncontinuable for six months

Design outcomes

Primary

MeasureTime frame
Left atrial volume indexed to body surface area, early-to-atrial left ventricular filling ratio, The ratio of transmitral Doppler early filling velocity to tissue Doppler early diastolic mitral annular velocity.

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026